Cargando…
A novel prostaglandin I(2) agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
BACKGROUND: ONO-1301 is a novel long-lasting prostaglandin (PG) I(2) mimetic with inhibitory activity on thromboxane (TX) A(2) synthase. This drug can also induce endogenous prostaglandin (PG)I2 and PGE2 levels. Furthermore, ONO-1301 acts as a cytokine inducer and can initiate tissue repair in a var...
Autores principales: | Motegi, Satoko, Tsuchiya, Atsunori, Iwasawa, Takahiro, Sato, Takeki, Kumagai, Masaru, Natsui, Kazuki, Nojiri, Shunsuke, Ogawa, Masahiro, Takeuchi, Suguru, Sakai, Yosiki, Miyagawa, Shigeru, Sawa, Yoshiki, Terai, Shuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805395/ https://www.ncbi.nlm.nih.gov/pubmed/35101153 http://dx.doi.org/10.1186/s41232-021-00191-6 |
Ejemplares similares
-
Innovative therapeutic strategy using prostaglandin I(2) agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension
por: Kanaya, Tomomitsu, et al.
Publicado: (2021) -
Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
por: Iwasawa, Takahiro, et al.
Publicado: (2021) -
A sustained-release drug-delivery system of synthetic prostacyclin agonist, ONO-1301SR: a new reagent to enhance cardiac tissue salvage and/or regeneration in the damaged heart
por: Fukushima, Satsuki, et al.
Publicado: (2015) -
Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice
por: Nojiri, Shunsuke, et al.
Publicado: (2021) -
Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
por: Tsuchiya, Atsunori, et al.
Publicado: (2020)